Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Discrepancies between disk diffusion and broth susceptibility studies of the activity of ticarcillin plus clavulanic acid against ticarcillin-resistant Pseudomonas aeruginosa.

Antimicrobial Agents and Chemotherapy, 01 Jul 1986, 30(1):35-38
https://doi.org/10.1128/aac.30.1.35 PMID: 3092732 PMCID: PMC176430

Free full text in Europe PMC

Abstract 

Ticarcillin and clavulanic acid in combination were tested against 40 Pseudomonas aeruginosa isolates resistant to ticarcillin by disk diffusion. A total of 21 isolates (53%) were susceptible to ticarcillin-clavulanate by disk diffusion, under currently recommended criteria for ticarcillin susceptibility. Macro-broth dilution tests (ticarcillin plus clavulanic acid, 2 micrograms/ml) confirmed susceptibility (MIC less than or equal to 64 micrograms/ml) of only 8 (38%) of 21 isolates. Time-kill studies of disk diffusion susceptible isolates indicated 2 log10 or greater killing of most isolates at 6 h in broth containing ticarcillin (64 micrograms/ml) combined with clavulanic acid (1, 2, 5, or 10 micrograms/ml). After 6 h, regrowth was common in all concentrations of clavulanic acid except 10 micrograms/ml. Regrowth populations were resistant to ticarcillin-clavulanate by MIC determination. Poor bactericidal activity of ticarcillin-clavulanate against ticarcillin-resistant P. aeruginosa was confirmed, as most isolates did not undergo 99.9% or greater killing at 24 h in all concentrations of clavulanic acid. Serotype O-11 was our most common serotype and was associated with disk diffusion "pseudosusceptibility." Concomitant disk diffusion testing of ticarcillin-clavulanate and ticarcillin is recommended for testing the susceptibility of P. aeruginosa to ticarcillin-clavulanate by disk diffusion. P. aeruginosa isolates resistant to ticarcillin should as a rule be considered also resistant to ticarcillin-clavulanate, despite apparent susceptibility by disk diffusion.

Free full text 

Logo of aacLink to Publisher's site
Antimicrob Agents Chemother. 1986 Jul; 30(1): 35–38.
PMCID: PMC176430
PMID: 3092732

Discrepancies between disk diffusion and broth susceptibility studies of the activity of ticarcillin plus clavulanic acid against ticarcillin-resistant Pseudomonas aeruginosa.

F A Manian and R H Alford
Copyright and License information Disclaimer

Abstract

Ticarcillin and clavulanic acid in combination were tested against 40 Pseudomonas aeruginosa isolates resistant to ticarcillin by disk diffusion. A total of 21 isolates (53%) were susceptible to ticarcillin-clavulanate by disk diffusion, under currently recommended criteria for ticarcillin susceptibility. Macro-broth dilution tests (ticarcillin plus clavulanic acid, 2 micrograms/ml) confirmed susceptibility (MIC less than or equal to 64 micrograms/ml) of only 8 (38%) of 21 isolates. Time-kill studies of disk diffusion susceptible isolates indicated 2 log10 or greater killing of most isolates at 6 h in broth containing ticarcillin (64 micrograms/ml) combined with clavulanic acid (1, 2, 5, or 10 micrograms/ml). After 6 h, regrowth was common in all concentrations of clavulanic acid except 10 micrograms/ml. Regrowth populations were resistant to ticarcillin-clavulanate by MIC determination. Poor bactericidal activity of ticarcillin-clavulanate against ticarcillin-resistant P. aeruginosa was confirmed, as most isolates did not undergo 99.9% or greater killing at 24 h in all concentrations of clavulanic acid. Serotype O-11 was our most common serotype and was associated with disk diffusion "pseudosusceptibility." Concomitant disk diffusion testing of ticarcillin-clavulanate and ticarcillin is recommended for testing the susceptibility of P. aeruginosa to ticarcillin-clavulanate by disk diffusion. P. aeruginosa isolates resistant to ticarcillin should as a rule be considered also resistant to ticarcillin-clavulanate, despite apparent susceptibility by disk diffusion.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (875K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
icon of scanned page 35
35
icon of scanned page 36
36
icon of scanned page 37
37
icon of scanned page 38
38
 

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bailey RR, Peddie B, Blake E, Bishop V, Reddy J. Cefoperazone in the treatment of severe or complicated infections. Drugs. 1981;22 (Suppl 1):76–86. [Abstract] [Google Scholar]
  • Barry AL, Ayers LW, Gavan TL, Gerlach EH, Jones RN. In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centers. Eur J Clin Microbiol. 1984 Jun;3(3):203–206. [Abstract] [Google Scholar]
  • Bennett S, Wise R, Weston D, Dent J. Pharmacokinetics and tissue penetration of ticarcillin combined with clavulanic acid. Antimicrob Agents Chemother. 1983 Jun;23(6):831–834. [Europe PMC free article] [Abstract] [Google Scholar]
  • Casey P, Glauser M. Susceptibility of gram-negative bacteria and Staphylococcus aureus to combinations of ticarcillin and clavulanic acid. Eur J Clin Microbiol. 1983 Dec;2(6):541–547. [Abstract] [Google Scholar]
  • Chattopadhyay B, Hall I. In vitro activity of ticarcillin plus clavulanic acid (BRL 28500, 'Timentin') against ticarcillin-resistant gram-negative rods. Curr Med Res Opin. 1984;9(3):157–160. [Abstract] [Google Scholar]
  • Clarke AM, Zemcov SJ. Clavulanic acid in combination with ticarcillin: an in-vitro comparison with other beta-lactams. J Antimicrob Chemother. 1984 Feb;13(2):121–128. [Abstract] [Google Scholar]
  • Ericsson HM, Sherris JC. Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol Microbiol Scand B Microbiol Immunol. 1971;217(Suppl):1+–1+. [Abstract] [Google Scholar]
  • Farmer JJ, 3rd, Weinstein RA, Zierdt CH, Brokopp CD. Hospital outbreaks caused by Pseudomonas aeruginosa: importance of serogroup O11. J Clin Microbiol. 1982 Aug;16(2):266–270. [Europe PMC free article] [Abstract] [Google Scholar]
  • Fuchs PC, Barry AL, Thornsberry C, Jones RN. In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates. Antimicrob Agents Chemother. 1984 Mar;25(3):392–394. [Europe PMC free article] [Abstract] [Google Scholar]
  • Fuchs PC, Jones RN, Barry AL, Thornsberry C. Disk diffusion susceptibility testing of ticarcillin plus clavulanic acid. J Clin Microbiol. 1984 Apr;19(4):555–557. [Europe PMC free article] [Abstract] [Google Scholar]
  • Gwynn MN, Webb TL, Rolinson GN. Regrowth of Pseudomonas aeruginosa and other bacteria after the bactericidal action of carbenicillin and other beta-lactam antibiotics. J Infect Dis. 1981 Sep;144(3):263–269. [Abstract] [Google Scholar]
  • Henry D, Skidmore AG, Ngui-Yen J, Smith A, Smith JA. In vitro activities of enoxacin, ticarcillin plus clavulanic acid, aztreonam, piperacillin, and imipenem and comparison with commonly used antimicrobial agents. Antimicrob Agents Chemother. 1985 Aug;28(2):259–264. [Europe PMC free article] [Abstract] [Google Scholar]
  • Hunter PA, Coleman K, Fisher J, Taylor D. In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin. J Antimicrob Chemother. 1980 Jul;6(4):455–470. [Abstract] [Google Scholar]
  • Mathisen GE, Meyer RD, Thompson JM, Finegold SM. Clinical evaluation of moxalactam. Antimicrob Agents Chemother. 1982 May;21(5):780–786. [Europe PMC free article] [Abstract] [Google Scholar]
  • Murray PR, Granich GG, Krogstad DJ, Niles AC. In vivo selection of resistance to multiple cephalosporins by enterobacter cloacae. J Infect Dis. 1983 Mar;147(3):590–590. [Abstract] [Google Scholar]
  • Neu HC, Fu KP. Clavulanic acid, a novel inhibitor of beta-lactamases. Antimicrob Agents Chemother. 1978 Nov;14(5):650–655. [Europe PMC free article] [Abstract] [Google Scholar]
  • Paisley JW, Washington JA., 2nd Combined activitiy of clavulanic acid and ticarcillin against ticarcillin-resistant, gram-negative bacilli. Antimicrob Agents Chemother. 1978 Aug;14(2):224–227. [Europe PMC free article] [Abstract] [Google Scholar]
  • Parry MG, Neu HC. Ticarcillin for treatment of serious infections with gram-negative bacteria. J Infect Dis. 1976 Nov;134(5):476–485. [Abstract] [Google Scholar]
  • Preheim LC, Penn RG, Sanders CC, Goering RV, Giger DK. Emergence of resistance to beta-lactam and aminoglycoside antibiotics during moxalactam therapy of Pseudomonas aeruginosa infections. Antimicrob Agents Chemother. 1982 Dec;22(6):1037–1041. [Europe PMC free article] [Abstract] [Google Scholar]
  • Reading C, Cole M. Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus. Antimicrob Agents Chemother. 1977 May;11(5):852–857. [Europe PMC free article] [Abstract] [Google Scholar]
  • Rylander M, Brorson JE, Johnsson J, Norrby R. Comparison between agar and broth minimum inhibitory concentrations of cefamandole, Cefoxitin, and cefuroxime. Antimicrob Agents Chemother. 1979 Apr;15(4):572–579. [Europe PMC free article] [Abstract] [Google Scholar]
  • Sanders CC, Moellering RC, Jr, Martin RR, Perkins RL, Strike DG, Gootz TD, Sanders WE., Jr Resistance to cefamandole: a collaborative study of emerging clinical problems. J Infect Dis. 1982 Jan;145(1):118–125. [Abstract] [Google Scholar]
  • Stratton CW. Susceptibility testing revisited. Prog Clin Pathol. 1984;9:65–100. [Abstract] [Google Scholar]
Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

Full text links 

Read article at publisher's site: https://doi.org/10.1128/aac.30.1.35

Read article for free, from open access legal sources, via Unpaywall: https://europepmc.org/articles/pmc176430?pdf=renderUnpaywall

Citations & impact 

Impact metrics

3
Citations
Jump to Citations

Citations of article over time

Article citations

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.